Comorbidities: A Decider of Severe Clinical Outcomes in COVID-19 Patients

被引:0
|
作者
Agrawal, Rahul [1 ]
机构
[1] Datta Meghe Inst Med Sci Deemed Univ, Dept Community Med, Jawaharlal Nehru Med Coll, Wardha 442001, Maharashtra, India
关键词
COVID-19; diabetes; CVD; COPD; comorbidity; obesity; hypertension; renal ailments; DIABETES-MELLITUS; RISK-FACTORS;
D O I
10.9734/JPRI/2021/v33i39A32133
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Comorbidity is the biggest decider in COVID-19 pandemic whether the infected person will develop the severe clinical outcome or not. It is one of the few conclusions that has widespread acceptance. Summary:After analyzing the case fatalities of COVID-19, many patients were found to be having either one of many conditions which are commonly called as comorbidities due to which they cannot made it to survivors list. Also several COVID-19 patients requiring the sophisticated medical attention like ventilators and oxygen support system have any kind of underlying medical condition. Deteriorated immune system is one of the reasons behind slipping into severe symptoms category. Conclusion: It is established that comorbidities are the major influencer in COVID-19 infected patients. More study is needed to further segregate the data on the basis of each comorbidity.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] COVID-19, COMORBIDITIES, AND OUTCOMES IN SEVERE ILLNESS
    Hooshmand, Kevin
    Wilden, Ana
    Zaman, Ishica
    Dorroh, James
    Reed, Mark
    Holliday, Zachary
    [J]. CHEST, 2021, 160 (04) : 1110A - 1110A
  • [2] Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
    Yan, Yongli
    Yang, Yan
    Wang, Fen
    Ren, Huihui
    Zhang, Shujun
    Shi, Xiaoli
    Yu, Xuefeng
    Dong, Kun
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [3] Outcomes of COVID-19 patients with comorbidities in southwest Nigeria
    Osibogun, Akin
    Balogun, Mobolanle
    Abayomi, Akin
    Idris, Jide
    Kuyinu, Yetunde
    Odukoya, Oluwakemi
    Wright, Ololade
    Adeseun, Remi
    Mutiu, Bamidele
    Saka, Babatunde
    Osa, Nike
    Lajide, Dayo
    Abdus-Salam, Ismael
    Osikomaiya, Bodunrin
    Onasanya, Oluwatosin
    Adebayo, Bisola
    Oshodi, Yewande
    Adesola, Sunday
    Adejumo, Olu
    Erinoso, Olufemi
    Abdur-Razzaq, Hussein
    Bowale, Abimbola
    Akinroye, Kingsley
    [J]. PLOS ONE, 2021, 16 (03):
  • [4] Comorbidities and clinical features related to severe outcomes among COVID-19 cases in Selangor, Malaysia
    Hasani, Wan Shakira Rodzlan
    Ganapathy, Shubash Shander
    Lin, Chong Zhuo
    Rifin, Halizah Mat
    Bahari, Mohammad Nazarudin
    Ghazali, Muhammad Haikal
    Lodz, Noor Aliza
    Ramli, Muhd Hafizuddin Taufik
    Ab Majid, Nur Liana
    Ling, Miaw Yn Jane
    Yusoff, Muhammad Fadhli Mohd
    Ahmad, Noor Ani
    Suleiman, Anita
    Yusoff, Ahmad Faudzi
    Balanb, Venugopalan
    Ngadiman, Sha'ari
    [J]. WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2021, 12 (01)
  • [5] COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
    Bigdelou, Banafsheh
    Sepand, Mohammad Reza
    Najafikhoshnoo, Sahar
    Negrete, Jorge Alfonso Tavares
    Sharaf, Mohammed
    Ho, Jim Q.
    Sullivan, Ian
    Chauhan, Prashant
    Etter, Manina
    Shekarian, Tala
    Liang, Olin
    Hutter, Gregor
    Esfandiarpour, Rahim
    Zanganeh, Steven
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Are patients with comorbidities more prone to sequalae in severe COVID-19
    Daga, Mradul Kumar
    Mawari, Govind
    Chand, Siddharth
    Aarthi, J.
    Raghu, R. V.
    Kumar, Naresh
    [J]. INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (03) : 161 - 164
  • [7] Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19
    Cheng, Xiaocheng
    Cai, Guoqiang
    Wen, Xuesong
    Gao, Lei
    Jiang, Dan
    Sun, Min
    Qin, Shu
    Zhou, Jianzhong
    Zhang, Dongying
    [J]. AGING-US, 2020, 12 (23): : 23436 - 23449
  • [8] Immunosuppressed patients with severe COVID-19 pneumonia: clinical characteristics and outcomes
    Forin, Edoardo
    Galli, Flavia
    Molina Saldarriaga, Francisco Jose
    Motos, Anna
    Misuraca, Sofia
    Barbeta, Enric
    Canseco, Joan
    Fernandez-Barat, Laia
    Catalina Palomeque, Andrea
    Bermejo Martin, Jesus Francisco
    Barbe Illa, Ferran
    Torres, Antoni
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [9] Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes
    Al-Baadani, Abeer
    Eltayeb, Nazik
    Alsufyani, Eid
    Albahrani, Salma
    Basheri, Shareefah
    Albayat, Hawra
    Batubara, Enas
    Ballool, Sulafa
    Al Assiri, Ayed
    Faqihi, Fahad
    Musa, Ali B.
    Robert, Asirvatham A.
    Alsherbeeni, Nisreen
    Elzein, Fatehi
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (08) : 1021 - 1027
  • [10] Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19
    Li, Junli
    Xu, Ge
    Yu, Heping
    Peng, Xiang
    Luo, Yongwen
    Cao, Cheng'an
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2020, 360 (03): : 229 - 235